Company Info
Phone(609) 430-2481
Year Established
1999
Ticker
GMAB
Exchange
NASDAQ
Contacts
Jan G. J. van de Winkel, Ph.D.President & CEO
Company Description
Genmab is an international biotechnology company with a core purpose guiding its unstoppable team to strive towards improving the lives of patients through innovative and differentiated antibody therapeutics.